Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Nataliya P. Kolosova"'
Autor:
Victor A. Svyatchenko, Vladimir A. Ternovoi, Roman Y. Lutkovskiy, Elena V. Protopopova, Andrei S. Gudymo, Nataliya V. Danilchenko, Ivan M. Susloparov, Nataliya P. Kolosova, Alexander B. Ryzhikov, Oleg S. Taranov, Vladimir V. Omigov, Elena V. Gavrilova, Alexander P. Agafonov, Rinat A. Maksyutov, Valery B. Loktev
Publikováno v:
Microorganisms, Vol 11, Iss 1, p 180 (2023)
In this study, we investigated the features of the infectious process by simulating co-infection with SARS-CoV-2 and human adenovirus type 5 (HAdV-5) or influenza A virus (IAV) in vitro and in vivo. The determination of infectious activity of viruses
Externí odkaz:
https://doaj.org/article/e311637d3eb048bf852c1a84aba12e18
Publikováno v:
BMC Medical Genomics, Vol 12, Iss S2, Pp 133-140 (2019)
Abstract Background Age-related macular degeneration (AMD) is a major cause of blindness in developed countries, and the molecular pathogenesis of AMD is poorly understood. A large body of evidence has corroborated the key role of neurotrophins in de
Externí odkaz:
https://doaj.org/article/599f62b23ae44f5aab4c74928c1df138
Autor:
Oyuna S. Kozhevnikova, Anzhella Zh. Fursova, Anna S. Derbeneva, Ida F. Nikulich, Mikhail S. Tarasov, Vasiliy A. Devyatkin, Yulia V. Rumyantseva, Darya V. Telegina, Nataliya G. Kolosova
Publikováno v:
Biomedicines, Vol 10, Iss 7, p 1658 (2022)
Neovascular age-related macular degeneration (nAMD) is the leading cause of vision loss in the elderly. The gold standard of nAMD treatment is intravitreal injections of vascular endothelial growth factor (VEGF) inhibitors. Genetic factors may influe
Externí odkaz:
https://doaj.org/article/4f0800209b1a4783a9db6b3470110dce
Autor:
Ekaterina A. Rudnitskaya, Tatiana A. Kozlova, Alena O. Burnyasheva, Anna E. Tarasova, Tatiana M. Pankova, Marina V. Starostina, Natalia A. Stefanova, Nataliya G. Kolosova
Publikováno v:
Frontiers in Neuroscience, Vol 14 (2020)
Aging is the major risk factor of the most common (∼95% of cases) sporadic Alzheimer’s disease (AD). Accumulating data indicate middle age as a critical period for the relevant pathological processes, however, the question of when AD starts to de
Externí odkaz:
https://doaj.org/article/7162feb079b6451a9eea47ce7817906b
Autor:
Maria A. Tikhonova, Tamara G. Amstislavskaya, Victor M. Belichenko, Larisa A. Fedoseeva, Sergey P. Kovalenko, Ekaterina E. Pisareva, Alla S. Avdeeva, Nataliya G. Kolosova, Nikolai D. Belyaev, Lyubomir I. Aftanas
Publikováno v:
BMC Neuroscience, Vol 19, Iss S1, Pp 15-28 (2018)
Abstract Background The dominant hypothesis about the pathogenesis of Alzheimer’s disease (AD) is the “amyloid cascade” concept and modulating the expression of proteins involved in the metabolism of amyloid-beta (Aβ) is proposed as an effecti
Externí odkaz:
https://doaj.org/article/e36633a412f3407296603b97987811c4
Autor:
Natalia A. Stefanova, Kseniya Yi Maksimova, Ekaterina A. Rudnitskaya, Natalia A. Muraleva, Nataliya G. Kolosova
Publikováno v:
BMC Genomics, Vol 19, Iss S3, Pp 51-63 (2018)
Abstract Background Cerebrovascular dysfunction plays a critical role in the pathogenesis of Alzheimer’s disease (AD): the most common cause of dementia in the elderly. The involvement of neurovasculature disorders in the progression of AD is now i
Externí odkaz:
https://doaj.org/article/1f226daf26224dd89e05387d2e1b2236
Autor:
Ekaterina A. Rudnitskaya, Tatiana A. Kozlova, Alena O. Burnyasheva, Natalia A. Stefanova, Nataliya G. Kolosova
Publikováno v:
Biomedicines, Vol 9, Iss 7, p 823 (2021)
Sporadic Alzheimer’s disease (AD) is a severe disorder of unknown etiology with no definite time frame of onset. Recent studies suggest that middle age is a critical period for the relevant pathological processes of AD. Nonetheless, sufficient data
Externí odkaz:
https://doaj.org/article/37543dbbf808423ab62e0775c8381721
Publikováno v:
Antioxidants, Vol 10, Iss 7, p 1058 (2021)
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and the most common cause of dementia worldwide, with no cure. There is growing interest in mitogen-activated protein kinases (MAPKs) as possible pathogenesis-related therapeutic
Externí odkaz:
https://doaj.org/article/a66b207e622841d18b431a796f74506c
Publikováno v:
Antioxidants, Vol 9, Iss 8, p 676 (2020)
Alzheimer’s disease (AD) is the most common type of dementia and is currently incurable, and mitogen-activated protein kinase (MAPK) p38 is implicated in the pathogenesis of AD. p38 MAPK inhibition is considered a promising strategy against AD, but
Externí odkaz:
https://doaj.org/article/3d34f2613a724bf8b4006c1cee0d6014
Publikováno v:
Antioxidants, Vol 8, Iss 6, p 177 (2019)
Age-related macular degeneration (AMD) is a major cause of irreversible visual impairment and blindness in developed countries, and the molecular pathogenesis of AMD is poorly understood. Recent studies strongly indicate that amyloid β (Aβ) accumul
Externí odkaz:
https://doaj.org/article/7ed21dcc0a884f21a27074ad8151e515